Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-28 @ 2:52 PM
Study NCT ID:
NCT02292550
Status:
COMPLETED
Last Update Posted:
2020-12-17
First Post:
2014-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Safety and Efficacy of LEE011 and Ceritinib in Patients With ALK-positive Non-small Cell Lung Cancer.
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-12
First Submit QC Date:
None
Study First Post Date:
2014-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-17
Last Update Post Date Type:
ACTUAL